Search Results - Daniel Rauh
- Showing 1 - 20 results of 31
- Go to Next Page
-
1
-
2
-
3
Spotlight on AKT: Current Therapeutic Challenges by Ina Landel, Lena Quambusch, Laura Depta, Daniel Rauh
Published 2020Artigo -
4
-
5
-
6
-
7
-
8
-
9
Highly Enantioselective Catalytic Synthesis of Neurite Growth-Promoting Secoyohimbanes by Andrey P. Antonchick, S. López-Tosco, Juan A. Parga, Sonja Sievers, Markus Schürmann, Hans Preut, Susanne Höing, Hans R. Schöler, Jared Sterneckert, Daniel Rauh, Herbert Waldmann
Published 2013Artigo -
10
An Unbiased Cell Morphology–Based Screen for New, Biologically Active Small Molecules by Masahiro Tanaka, Raynard L. Bateman, Daniel Rauh, Eugeni Vaisberg, Shyam Ramachandani, Chao Zhang, Kirk C. Hansen, Alma L. Burlingame, J. K. Trautman, Kevan M. Shokat, Cynthia L. Adams
Published 2005Artigo -
11
A novel scaffold for EGFR inhibition: Introducing N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives by Daniel N. do Amaral, Jonas Lategahn, Harold Hilarion Fokoue, Eduardo Miguez Bastos da Silva, Carlos Maurício R. Sant’Anna, Daniel Rauh, Eliezer J. Barreiro, Stefan Laufer, Lı́dia Moreira Lima
Published 2019Artigo -
12
Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA by Alina Teuber, Tom Schulz, B. S. Fletcher, Rajesh Gontla, Thomas Mühlenberg, Mia‐Lisa Zischinsky, Janina Niggenaber, Jörn Weisner, Silke Kleinbölting, Jonas Lategahn, Sonja Sievers, Matthias Müller, Sebastian Bauer, Daniel Rauh
Published 2024Artigo -
13
ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors by Johannes M. Heuckmann, Michael Hölzel, Martin L. Sos, Stefanie Heynck, Hyatt Balke‐Want, Mirjam Koker, Martin Peifer, Jonathan M. Weiss, Christine M. Lovly, Christian Grütter, Daniel Rauh, William Pao, Roman K. Thomas
Published 2011Artigo -
14
Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34 by Lucas Robke, Luca Laraia, Marjorie A. Carnero Corrales, Georgios Konstantinidis, Makoto Muroi, André Richters, Michael Winzker, Tobias Engbring, Stefano Tomassi, Nobumoto Watanabe, Hiroyuki Osada, Daniel Rauh, Herbert Waldmann, Yao‐Wen Wu, Julian Engel
Published 2017Artigo -
15
Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt by Niklas Uhlenbrock, Steven P. Smith, Jörn Weisner, Ina Landel, Marius Lindemann, Thien Anh Le, Julia Hardick, Rajesh Gontla, Rebekka Scheinpflug, Paul Czodrowski, Petra Janning, Laura Depta, Lena Quambusch, Matthias Müller, Bernd Engels, Daniel Rauh
Published 2019Artigo -
16
Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer by Sampurna Chatterjee, Lukas C. Heukamp, Maike Siobal, Jakob Schöttle, Caroline Wieczorek, Martin Peifer, Davide Frasca, Mirjam Koker, Katharina König, Lydia Meder, Daniel Rauh, Reinhard Buettner, Jürgen Wolf, Rolf A. Brekken, Bernd Neumaier, Gerhard Christofori, Roman K. Thomas, Roland T. Ullrich
Published 2013Artigo -
17
Resistance to Avapritinib in PDGFRA-Driven GIST Is Caused by Secondary Mutations in the PDGFRA Kinase Domain by Susanne Grünewald, Lillian R. Klug, Thomas Mühlenberg, Jonas Lategahn, Johanna Falkenhorst, Ajia Town, Christiane Ehrt, Eva Wardelmann, Wolfgang Hartmann, Hans‐Ulrich Schildhaus, Juergen Treckmann, Jonathan A. Fletcher, Sascha Jung, Paul Czodrowski, Steven P. Miller, Oleg Schmidt-Kittler, Daniel Rauh, Michael C. Heinrich, Sebastian Bauer
Published 2020Carta -
18
Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation by Martin L. Sos, Haridas B. Rode, Stefanie Heynck, Martin Peifer, Florian Fischer, Sabine Klüter, Vijaykumar G. Pawar, Cecile Reuter, Johannes M. Heuckmann, Jonathan M. Weiss, Lars Ruddigkeit, Matthias Rabiller, Mirjam Koker, Jeffrey R. Simard, Matthäus Getlik, Yuki Yuza, Tzu-Hsiu Chen, Heidi Greulich, Roman K. Thomas, Daniel Rauh
Published 2010Artigo -
19
A framework for identification of actionable cancer genome dependencies in small cell lung cancer by Martin L. Sos, Felix Dietlein, Martin Peifer, Jakob Schöttle, Hyatt Balke‐Want, Christian Müller, Mirjam Koker, André Richters, Stefanie Heynck, Florian Malchers, Johannes M. Heuckmann, Danila Seidel, Patrick A. Eyers, Roland T. Ullrich, Andrey P. Antonchick, Viktor V. Vintonyak, Peter M. Schneider, Takashi Ninomiya, Herbert Waldmann, Reinhard Büttner, Daniel Rauh, Lukas C. Heukamp, Roman K. Thomas
Published 2012Artigo -
20
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer by Felix Dietlein, Bastian Kalb, Mladen Jokić, Elisa M. Noll, Alexander Strong, Lars Tharun, Luka Ozretić, Helen Künstlinger, Kato Kambartel, Winfried Randerath, Christian Jüngst, Anna Schmitt, Alessandro Torgovnick, André Richters, Daniel Rauh, Florian Siedek, Thorsten Persigehl, Cornelia Mauch, Jiřina Bártková, Allan Bradley, Martin R. Sprick, Andreas Trumpp, Roland Rad, Dieter Saur, Jiří Bártek, Jürgen Wolf, Reinhard Büttner, Roman K. Thomas, Hans Christian Reinhardt
Published 2015Artigo
Search Tools:
Related Subjects
Biology
Cancer research
Gene
Genetics
Medicine
Mutant
Biochemistry
Cancer
Chemistry
Receptor
Computational biology
Kinase
Cell biology
Internal medicine
Lung cancer
Epidermal growth factor receptor
Mutation
Pharmacology
EGFR inhibitors
Erlotinib
Oncology
Drug resistance
Gefitinib
Osimertinib
PI3K/AKT/mTOR pathway
Signal transduction
Small molecule
T790M
Bioinformatics
Computer science